GO:0036258 multivesicular body assembly: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036258 multivesicular body assembly describes the aggregation, arrangement and bonding of components to form a multivesicular body (MVB), a late endosome in which the limiting membrane invaginates to create internal vesicles.
• The ESCRT machinery (ESCRT-0, -I, -II, -III and Vps4) is the central protein system that drives cargo sorting and membrane invagination during MVB biogenesis.
• MVB assembly is essential for lysosomal degradation, receptor downregulation, extracellular vesicle formation and retrovirus budding.
• Defects in MVB assembly are linked to neurodevelopmental, neuromuscular and neurodegenerative disorders, cancer progression and vascular inflammation.
• Key genes include ESCRT components (TSG101, CHMP2A, CHMP4B, VPS4A/B), endosomal regulators (Rab7, Vps34, HRS) and cargo receptors such as CD151.
• CRISPR knockout, point mutation, knock-in and overexpression models enable causal dissection of MVB assembly genes in disease contexts.
Description
Multivesicular body (MVB) assembly is the biological process by which a late endosome forms internal vesicles through invagination of its limiting membrane, sequestering membrane proteins away from the cytoplasm. This process is fundamental to cellular homeostasis, as it controls the sorting of cargo destined for lysosomal degradation, the release of exosomes and the budding of certain enveloped viruses. The Gene Ontology term GO:0036258 captures the aggregation, arrangement and bonding of components required to build this specialized endosomal compartment. Researchers study MVB assembly because its dysfunction is increasingly recognized as a driver of human disease, including neurodegeneration, cancer and inflammatory disorders. Understanding the molecular machinery of MVB biogenesis provides opportunities for therapeutic intervention and biomarker discovery.
multivesicular body assembly At A Glance
| GO ID | GO:0036258 |
|---|---|
| GO term | multivesicular body assembly |
| Ontology | biological_process |
| Synonym | multivesicular body biogenesis; MVB biogenesis; MVB formation |
| Major function | Formation of internal vesicles within late endosomes for cargo sorting and lysosomal degradation |
| Key machinery | ESCRT-0, -I, -II, -III complexes and Vps4 ATPase |
| Cellular location | Late endosome / multivesicular body |
| Related processes | Endosomal sorting, exosome biogenesis, retrovirus budding |
What Is GO:0036258?
GO:0036258 multivesicular body assembly is defined as the aggregation, arrangement and bonding together of a set of components to form a multivesicular body, a type of late endosome in which regions of the limiting endosomal membrane invaginate to form internal vesicles; membrane proteins that enter the internal vesicles are sequestered from the cytoplasm. In simpler terms, it is the construction of a cellular compartment that packages membrane proteins into tiny internal bubbles for degradation or release.
Why Is multivesicular body assembly Important in Cell Biology?
MVB assembly is a central node in endosomal trafficking, controlling the degradation of signaling receptors, the release of extracellular vesicles and the egress of viruses such as HIV and hepatitis B. Its dysregulation contributes to cancer stemness, vascular inflammation and neurodegeneration, making it a high-value target for both mechanistic studies and therapeutic development.
• Controls lysosomal degradation of membrane receptors, thereby regulating cell signaling.
• Required for exosome biogenesis and intercellular communication.
• Essential for retrovirus budding and hepatitis B virus egress.
• Implicated in neurodevelopmental and neurodegenerative disorders due to defective autophagy.
• Promotes cancer stemness and progression in hepatocellular carcinoma.
• Maintains endolysosomal protein quality to inhibit vascular inflammation.
• Involved in autophagic cell death regulation via ESCRT-III assembly.
• Provides targets for CRISPR-based functional genomics in disease models.
What Happens During multivesicular body assembly?
Cargo recognition and ESCRT-0 recruitment
In simple terms: The cell tags proteins for degradation and the first sorting complex grabs them.
MVB assembly begins with the recognition of ubiquitinated cargo on the endosomal membrane by ESCRT-0, which recruits downstream ESCRT complexes. This step ensures that membrane proteins destined for internal vesicles are selected and concentrated at specific microdomains.
Membrane invagination and ESCRT-III polymerization
In simple terms: The membrane bends inward and a protein scaffold forms to pinch off vesicles.
ESCRT-I and ESCRT-II coordinate cargo transfer to ESCRT-III, which polymerizes into filaments that drive membrane invagination and scission. The AAA-ATPase Vps4 disassembles ESCRT-III to complete vesicle formation. This mechanism is conserved from yeast to humans and is essential for MVB biogenesis.
Vesicle scission and cargo sequestration
In simple terms: The internal vesicles are cut free and their contents are hidden from the cytoplasm.
Following ESCRT-III-mediated constriction, the internal vesicles are released into the endosomal lumen, sequestering membrane proteins away from cytoplasmic signaling. This sequestration is critical for terminating receptor signaling and for preparing cargo for lysosomal degradation.
Fusion with lysosomes and cargo degradation
In simple terms: The multivesicular body merges with the lysosome to destroy its contents.
Mature MVBs fuse with lysosomes, delivering internal vesicles and their cargo for degradation. This step is regulated by Rab7 and other endosomal maturation factors. Defects in this fusion step can lead to cargo accumulation and cellular toxicity.
Key Genes Involved in GO:0036258 multivesicular body assembly
The following genes encode core components and regulators of multivesicular body assembly, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TSG101 | ESCRT-I component, cargo sorting | Knockout blocks MVB formation and virus budding |
| CHMP2A | ESCRT-III subunit, membrane scission | Point mutations impair vesicle formation |
| CHMP4B | ESCRT-III filament formation | Knockdown inhibits autophagic cell death |
| VPS4A | AAA-ATPase, ESCRT disassembly | Dominant-negative mutants trap ESCRT-III |
| VPS4B | AAA-ATPase, ESCRT disassembly | Knockout affects exosome release |
| HRS | ESCRT-0 subunit, cargo recognition | Knockdown mis-sorts ubiquitinated receptors |
| Rab7 | Late endosome maturation | Knockout impairs MVB-lysosome fusion |
| Vps34 | PI3K, endosomal sorting | Inhibition alters MVB morphology |
| CD151 | Tetraspanin, endolysosomal quality control | Knockout causes vascular inflammation |
| ATP6V1D | V-ATPase subunit, lysosome acidification | Knockout reduces HCC stemness |
| YAP1 | Transcriptional regulator, ESCRT-III assembly | Knockdown affects autophagic death |
| NEDD4L | E3 ubiquitin ligase, YAP1 degradation | Overexpression reduces ESCRT-III assembly |
| ErbB3 | Receptor tyrosine kinase, endosomal recycling | Loss redirects integrin β1 to EVs |
| Alix | ESCRT accessory protein | Knockdown impairs exosome biogenesis |
| VPS36 | ESCRT-II subunit | Knockout blocks MVB sorting |
| VPS25 | ESCRT-II subunit | Mutations affect receptor downregulation |
| VPS28 | ESCRT-I subunit | Knockdown inhibits HIV budding |
How Is multivesicular body assembly Regulated?
MVB assembly is regulated by ubiquitination of cargo and ESCRT components, phosphorylation of ESCRT subunits, and lipid modifications such as PI3P generation by Vps34. The AAA-ATPase Vps4 controls the dynamic cycle of ESCRT-III polymerization and disassembly, and its activity is essential for continuous MVB formation. Additionally, NEDD4L-mediated ubiquitination of YAP1 modulates ESCRT-III assembly during autophagic cell death.
multivesicular body assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP6V1D | Hepatocellular carcinoma stemness | Knockout in HCC cell lines |
| YAP1 | Breast cancer autophagic cell death | Point mutation and overexpression |
| CD151 | Vascular inflammation | Knockout in endothelial cells |
| ErbB3 | Extracellular vesicle cargo sorting | Knockout in mammary epithelial cells |
| TSG101 | HIV budding | Knockdown in HEK293T cells |
Neurodegenerative and neurodevelopmental disorders
Defective MVB assembly and autophagy contribute to a spectrum of neurodevelopmental, neuromuscular and neurodegenerative disorders, highlighting the importance of endolysosomal function in neuronal survival.
Cancer progression and stemness
In hepatocellular carcinoma, ATP6V1D drives stemness and progression through lysosome acidification-dependent and -independent mechanisms, linking MVB assembly to tumor aggressiveness. Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death in breast cancer, and its ubiquitination by NEDD4L regulates this process.
Vascular inflammation
CD151 maintains endolysosomal protein quality to inhibit vascular inflammation, demonstrating that MVB assembly components are critical for endothelial homeostasis.
Viral egress and infection
Retrovirus budding and hepatitis B virus egress depend on MVB assembly machinery, making these pathways relevant to antiviral research.
From multivesicular body assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ESCRT-I block MVB formation? | CRISPR knockout of TSG101 |
| Does a point mutation in CHMP2A impair vesicle scission? | Point mutation knock-in |
| Can tagged ESCRT-III be used to track MVB dynamics? | Tagged knock-in of CHMP4B |
| Does overexpression of YAP1 enhance autophagic death? | Overexpression in breast cancer cells |
| Does CD151 knockout cause vascular inflammation? | Knockout in endothelial cells |
| Does ATP6V1D knockout reduce HCC stemness? | Knockout in hepatocellular carcinoma cells |
How to Study the multivesicular body assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Electron microscopy | MVB morphology and internal vesicles | Ultrastructural analysis |
| Fluorescence microscopy | ESCRT localization and dynamics | Live-cell imaging |
| Mass spectrometry | Cargo protein composition | Exosome proteomics |
| CRISPR library screening | Genes required for MVB assembly | Functional genomics |
| Western blot | ESCRT protein levels | Knockout validation |
| Immunoprecipitation | ESCRT complex interactions | Mechanistic studies |
| Virus budding assay | Retrovirus release | Antiviral research |
Imaging MVB assembly
Electron microscopy and fluorescence microscopy visualize internal vesicles and ESCRT dynamics. Live-cell imaging of tagged ESCRT-III reveals real-time assembly.
Proteomic analysis of MVB cargo
Mass spectrometry identifies proteins sorted into MVBs and exosomes, revealing cargo specificity.
Genetic screens for MVB regulators
CRISPR library screening identifies genes required for MVB assembly and viral budding.
Biochemical assays for ESCRT function
In vitro reconstitution and ubiquitination assays measure ESCRT activity and cargo sorting.
How CRISPR Can Be Used to Study GO:0036258 multivesicular body assembly
Knockout
CRISPR knockout of ESCRT genes such as TSG101 or CHMP2A abolishes MVB formation and viral budding, providing causal evidence for their roles.
Point Mutation
Point mutations in ESCRT-III subunits like CHMP2A can be introduced to dissect specific steps of membrane scission without complete loss of protein.
Knock-in
Tagged knock-in of ESCRT components enables real-time tracking of MVB assembly dynamics in live cells.
Overexpression
Overexpression of YAP1 or NEDD4L modulates ESCRT-III assembly and autophagic cell death, allowing gain-of-function studies.
How EDITGENE Supports multivesicular body assembly Research
Researchers studying multivesicular body assembly-related genes often need to determine whether a candidate gene is causally involved in MVB formation, cargo sorting or disease progression. EDITGENE provides comprehensive CRISPR services to enable such functional validation.
Contact EDITGENE today to design your custom CRISPR model for multivesicular body assembly research.
Frequently Asked Questions About multivesicular body assembly
What is multivesicular body assembly?
It is the process of forming a late endosome with internal vesicles, defined by GO:0036258.
What genes are involved in multivesicular body assembly?
Key genes include TSG101, CHMP2A, CHMP4B, VPS4A, VPS4B, HRS, Rab7 and Vps34.
What is the role of ESCRT in MVB assembly?
ESCRT complexes recognize cargo, drive membrane invagination and scission to form internal vesicles.
How is multivesicular body assembly linked to disease?
Defects are associated with neurodegeneration, cancer stemness and vascular inflammation.
What is the difference between MVB and exosome?
MVBs are intracellular endosomes; exosomes are extracellular vesicles released upon MVB fusion with the plasma membrane.
Which viruses use MVB assembly for budding?
Retroviruses such as HIV and hepatitis B virus exploit MVB machinery for egress.
How can I study MVB assembly in the lab?
Use electron microscopy, fluorescence imaging, proteomics and CRISPR screens.
What CRISPR models are available for MVB genes?
Knockout, point mutation, knock-in and overexpression models can be custom-generated.
Is multivesicular body assembly conserved?
Yes, the ESCRT machinery is conserved from yeast to humans.
What diseases are linked to ESCRT dysfunction?
Neurodevelopmental disorders, cancer and inflammatory diseases.
Conclusion
Multivesicular body assembly (GO:0036258) is a fundamental cellular process that governs endosomal sorting, lysosomal degradation and extracellular vesicle release. Its core machinery, the ESCRT complexes, is conserved and essential for health, with dysfunction implicated in neurodegeneration, cancer and inflammation. CRISPR-based models provide powerful tools to dissect the causal roles of MVB genes in disease.
References
- 1. Deneubourg C et al.. 2022. The spectrum of neurodevelopmental, neuromuscular and neurodegenerative disorders due to defective autophagy.. Autophagy 18(3):496-517 PMID: 34130600
- 2. Demirov DG et al.. 2004. Retrovirus budding.. Virus Res 106(2):87-102 PMID: 15567490
- 3. Guo Y et al.. 2023. Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer.. Cancer Commun (Lond) 43(5):582-612 PMID: 37005481
- 4. Xu Z et al.. 2025. ATP6V1D drives hepatocellular carcinoma stemness and progression via both lysosome acidification-dependent and -independent mechanisms.. Autophagy 21(3):513-529 PMID: 39316516
- 5. Chen J et al.. 2024. CD151 Maintains Endolysosomal Protein Quality to Inhibit Vascular Inflammation.. Circ Res 134(10):1330-1347 PMID: 38557119
- 6. Chuang Y-C et al.. 2024. Hepatitis B virus entry, assembly, and egress.. Microbiol Mol Biol Rev 88(4):e0001424 PMID: 39440957
- 7. Remec Pavlin M et al.. 2020. The ESCRTs - converging on mechanism.. J Cell Sci 133(18) PMID: 32938689
- 8. Rodrigues-Junior DM et al.. 2026. Loss of ErbB3 redirects Integrin β1 from early endosomal recycling to secretion in extracellular vesicles.. J Cell Biol 225(1) PMID: 41348103
